298 related articles for article (PubMed ID: 30126113)
1. Patient-Derived Xenograft Models for Endometrial Cancer Research.
Moiola CP; Lopez-Gil C; Cabrera S; Garcia A; Van Nyen T; Annibali D; Fonnes T; Vidal A; Villanueva A; Matias-Guiu X; Krakstad C; Amant F; Gil-Moreno A; Colas E
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126113
[TBL] [Abstract][Full Text] [Related]
2. Genomic Validation of Endometrial Cancer Patient-Derived Xenograft Models as a Preclinical Tool.
Villafranca-Magdalena B; Masferrer-Ferragutcasas C; Lopez-Gil C; Coll-de la Rubia E; Rebull M; Parra G; García Á; Reques A; Cabrera S; Colas E; Gil-Moreno A; Moiola CP
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682944
[TBL] [Abstract][Full Text] [Related]
3. Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies.
Depreeuw J; Hermans E; Schrauwen S; Annibali D; Coenegrachts L; Thomas D; Luyckx M; Gutierrez-Roelens I; Debruyne D; Konings K; Moerman P; Vergote I; Lambrechts D; Amant F
Gynecol Oncol; 2015 Oct; 139(1):118-26. PubMed ID: 26232337
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived xenograft platform of OSCC: a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization.
Sun S; Zhang Z
Front Med; 2016 Mar; 10(1):104-10. PubMed ID: 26926009
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived xenografts: A platform for accelerating translational research in prostate cancer.
Davies AH; Wang Y; Zoubeidi A
Mol Cell Endocrinol; 2018 Feb; 462(Pt A):17-24. PubMed ID: 28315377
[TBL] [Abstract][Full Text] [Related]
6. Molecular and clinical implementations of ovarian cancer mouse avatar models.
Zayed AA; Mandrekar SJ; Haluska P
Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297
[TBL] [Abstract][Full Text] [Related]
7. Establishment of patient-derived cancer xenografts in immunodeficient NOG mice.
Chijiwa T; Kawai K; Noguchi A; Sato H; Hayashi A; Cho H; Shiozawa M; Kishida T; Morinaga S; Yokose T; Katayama M; Takenaka N; Suemizu H; Yamada R; Nakamura Y; Ohtsu T; Takano Y; Imai K; Miyagi Y; Nakamura M
Int J Oncol; 2015 Jul; 47(1):61-70. PubMed ID: 25963555
[TBL] [Abstract][Full Text] [Related]
8. Patient-derived xenografts: a valuable platform for clinical and preclinical research in pancreatic cancer.
Wang Y; Cui J; Wang L
Chin Clin Oncol; 2019 Apr; 8(2):17. PubMed ID: 30943729
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instable and microsatellite stable primary endometrial carcinoma cells and their subcutaneous and orthotopic xenografts recapitulate the characteristics of the corresponding primary tumor.
Schrauwen S; Coenegrachts L; Depreeuw J; Luyten C; Verbist G; Debruyne D; Vergote I; Lambrechts D; Amant F
Int J Gynecol Cancer; 2015 Mar; 25(3):363-71. PubMed ID: 25695543
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer.
Collins A; Miles GJ; Wood J; MacFarlane M; Pritchard C; Moss E
Gynecol Oncol; 2020 Jan; 156(1):251-259. PubMed ID: 31767187
[TBL] [Abstract][Full Text] [Related]
11. Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.
Haldorsen IS; Popa M; Fonnes T; Brekke N; Kopperud R; Visser NC; Rygh CB; Pavlin T; Salvesen HB; McCormack E; Krakstad C
PLoS One; 2015; 10(8):e0135220. PubMed ID: 26252891
[TBL] [Abstract][Full Text] [Related]
12. [Application and development of patient-derived tumor xenograft model in translational medicine of tumor].
Wang Z; Zhu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):596-600. PubMed ID: 28534338
[TBL] [Abstract][Full Text] [Related]
13. Beyond precision surgery: Molecularly motivated precision care for gastric cancer.
Choi YY; Cheong JH
Eur J Surg Oncol; 2017 May; 43(5):856-864. PubMed ID: 28330821
[TBL] [Abstract][Full Text] [Related]
14. Ovarian and cervical cancer patient derived xenografts: The past, present, and future.
Boone JD; Dobbin ZC; Straughn JM; Buchsbaum DJ
Gynecol Oncol; 2015 Aug; 138(2):486-91. PubMed ID: 26026736
[TBL] [Abstract][Full Text] [Related]
15. Patient Derived Xenografts (PDX) for personalized treatment of pancreatic cancer: emerging allies in the war on a devastating cancer?
Sereti E; Karagianellou T; Kotsoni I; Magouliotis D; Kamposioras K; Ulukaya E; Sakellaridis N; Zacharoulis D; Dimas K
J Proteomics; 2018 Sep; 188():107-118. PubMed ID: 29398619
[TBL] [Abstract][Full Text] [Related]
16. The future of patient-derived tumor xenografts in cancer treatment.
Sia D; Moeini A; Labgaa I; Villanueva A
Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers.
Lan T; Xue X; Dunmall LC; Miao J; Wang Y
Aging (Albany NY); 2021 Apr; 13(8):12273-12293. PubMed ID: 33903283
[TBL] [Abstract][Full Text] [Related]
18. Endometrial Cancer Patient-Derived Xenograft Models: A Systematic Review.
Tanaka T; Nishie R; Ueda S; Miyamoto S; Hashida S; Konishi H; Terada S; Kogata Y; Sasaki H; Tsunetoh S; Taniguchi K; Komura K; Ohmichi M
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566732
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived tumour xenografts for breast cancer drug discovery.
Cassidy JW; Batra AS; Greenwood W; Bruna A
Endocr Relat Cancer; 2016 Dec; 23(12):T259-T270. PubMed ID: 27702751
[TBL] [Abstract][Full Text] [Related]
20. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
Jung J; Seol HS; Chang S
Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]